MEDIROM Healthcare Technologies Return on Equity

The latest ROE for MRM is 15.55%. That is below the Consumer Discretionary sector average of 21.77%. Investors often review this figure alongside MEDIROM Healthcare Technologies's historical trend and sector peers before judging valuation or financial health.

Against Consumer Discretionary companies, MRM currently prints 15.55% for ROE, while the sector average sits near 21.77%. That is roughly 28.6% below the sector mean. Large gaps often invite a closer look at MEDIROM Healthcare Technologies's growth, margins, and balance sheet.

Return on Equity shows how effectively MEDIROM Healthcare Technologies converts resources into returns. At 15.55%, MRM may look efficient or underperforming depending on peer benchmarks and trend direction. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting MRM's ROE (15.55%), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack MEDIROM Healthcare Technologies's ROE against similar Consumer Discretionary names. You can also browse sector and industry screens on Stockcircle for a broader set of Consumer Discretionary companies and their key multiples and fundamentals.